Li; Chunsing

Patent Applications and Registrations

Patent applications and USPTO patent grants for Li; Chunsing.The latest application filed is for "3-(1h-pyrazol-4-yl)pyridine allosteric modulators of the m4 muscarinic acetylcholine receptor".

Company Profile

12.13.13

Li; Chunsing - Shanghai CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 11,339,156 - Acton, III , et al. May 24, 2	2022-05-24
6,5-fused heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 11,230,556 - Gao , et al. January 25, 2	2022-01-25
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20210395224 - Acton, III; John J. ; et al.	2021-12-23
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20210380580 - ACTON, III; John J. ; et al.	2021-12-09
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 11,149,036 - Acton, III , et al. October 19, 2	2021-10-19
5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,981,902 - Bao , et al. April 20, 2	2021-04-20
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,933,056 - Acton, III , et al. March 2, 2	2021-03-02
6,6-fused heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,836,775 - Gao , et al. November 17, 2	2020-11-17
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200207758 - ACTON, III; John J. ; et al.	2020-07-02
5-(pyridin-3-yl)oxazole Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200109137 - BAO; Jianming ; et al.	2020-04-09
6,5-fused Heteroaryl Piperidine Ether Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200095261 - GAO; Xiaolei ; et al.	2020-03-26
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200069671 - Acton, III; John J. ; et al.	2020-03-05
6,6-fused Heteroaryl Piperidine Ether Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20190315762 - GAO; Xiaolei ; et al.	2019-10-17
6,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,329,289 - Bao , et al.	2019-06-25
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20190000824 - Acton, III; John J. ; et al.	2019-01-03
Imidazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug Grant 9,981,969 - Coburn , et al. May 29, 2	2018-05-29
Factor XIa inhibitors Grant 9,868,727 - Liu , et al. January 16, 2	2018-01-16
Factor XIa Inhibitors App 20170210732 - Liu; Weiguo ; et al.	2017-07-27
Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug Grant 9,556,202 - Coburn , et al. January 31, 2	2017-01-31
Imidazole Derivatives And Methods Of Use Thereof For Improving The Pharmacokinetics Of A Drug App 20160108048 - Coburn; Craig A. ; et al.	2016-04-21
Sulfonamide Derivatives And Methods Of Use Thereof For Improving The Pharmacokinetics Of A Drug App 20150197531 - Coburn; Craig A. ; et al.	2015-07-16
Sulfonamide Derivatives And Methods Of Use Thereof For Improving The Pharmacokinetics Of A Drug App 20140005103 - Coburn; Craig A. ; et al.	2014-01-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.